From Idea to Medical Device: A Practical Introduction

Surgeons are well placed to notice problems that technology might solve. Turning an idea into a medical device, however, involves stages that are unfamiliar to most clinicians. This overview describes the general pathway in the UK. It is informational only; anyone taking an idea forward should seek support from their institution's innovation or technology transfer office and appropriate regulatory specialists.

Start with the clinical need

The most successful projects begin with a clearly defined unmet need rather than a solution looking for a problem. Structured approaches such as the Stanford Biodesign process encourage innovators to observe, record and prioritise needs before designing anything [1]. It helps to write a short need statement: the problem, the patients affected, and the outcome that would change.

Protect and share ideas carefully

Public disclosure, including at conferences or on social media, can affect the ability to patent an idea later. NHS employees should check their trust's intellectual property policy, as employers often have rights in inventions made in the course of employment. Many trusts and universities have innovation teams, and Health Innovation Networks can offer early support [2].

Understand whether it is a medical device

A product intended for diagnosis, prevention, monitoring or treatment is likely to be a medical device. In Great Britain the Medical Devices Regulations 2002 apply, and devices are classified by risk (Class I, IIa, IIb or III), which shapes the evidence and assessment needed [3]. Software may also qualify, and the MHRA publishes specific guidance on software and AI as a medical device [4].

Build quality and risk management in early

Manufacturers are generally expected to operate a quality management system, commonly aligned with ISO 13485, and to manage risk throughout the product life cycle using ISO 14971 [5,6]. For software, IEC 62304 describes life-cycle processes. Setting these up early is usually easier than retrofitting them.

Generate the right evidence

The IDEAL framework describes staged evaluation of surgical innovation, from first-in-human use through to long-term monitoring, and is widely used for new procedures and devices [7]. Early engagement with an ethics committee, the Health Research Authority and, where relevant, the MHRA helps to plan clinical investigation appropriately.

Plan for adoption

Regulatory approval does not guarantee use in the NHS. Commissioners and procurement teams will consider value, cost and fit with existing pathways, and NICE may assess the technology through its medical technologies or early value assessment programmes [8].

Summary

The path from idea to device is long and multidisciplinary. Defining the need clearly, protecting intellectual property, understanding regulatory classification and planning evidence from the outset can save considerable time. ASTI hopes to support members through education and signposting as its innovation programme develops.